valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

Teladoc Health, Inc. (TDOC) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$1.80 ComplexityAverage Updated
$0.80 $4.80
bear $0.80 base $3.70 bull $4.80 margin of safety $1.80 market price* $5.67
Teladoc Health sells virtual care in two segments. Integrated Care (about $1.58 billion of 2025 revenue) sells access-fee contracts to employers, health plans and health systems for virtual primary care, mental health, chronic-condition management (the former Livongo diabetes and hypertension programs) and telehealth visits. BetterHelp (about $950 million) sells online therapy directly to consumers. Total revenue was $2.53 billion in 2025, down 2% from $2.57 billion, because BetterHelp fell 9% (average monthly paying users down 5%) while Integrated Care grew 3%, about two points of that from acquisitions (Catapult Health, Telecare). How we measure earnings. Teladoc reports large accounting losses, mostly from non-cash charges: a $790 million goodwill write-down in 2024, a $72 million write-down in 2025, and roughly $350 million a year of amortization of acquired intangibles and capitalized software. We add back the non-cash items but deduct two real costs: stock compensation ($80 million in 2025, down from $146 million in 2024 and $202 million in 2023) and the cash spent on capitalized software development (about $119 million in 2025) plus ordinary capital expenditure ($9 million). Treating software spending as a recurring cost matters; ignoring it would overstate earnings by about $120 million a year. Owner earnings per share were roughly $(0.92) in 2021, $(0.90) in 2022, $(0.12) in 2023, $0.29 in 2024 and $0.41 in 2025 (about $72 million in 2025). The improvement is real and comes chiefly from lower stock compensation and lower software spend than in 2022-2023, with operating cash flow steady near $294 million. We start from the post-merger period (the Livongo merger closed in late 2020) and use $0.35 per share, the midpoint of 2024 and 2025, because 2021-2023 carried much higher stock compensation and a cost structure that no longer exists. Last year's actual growth in owner earnings per share was about 41%; we assume a decline, not growth, in year one, so there is no reliance on the recent jump continuing. Base case: $3.70 per share. Earnings of about $0.35 per share drift down 2% a year for ten years, matching the 2025 revenue trend, then fade 5% a year afterward. What keeps value going is the access-fee model: contracted, recurring client revenue where the top five clients are 19% of total revenue. What we leave out: any BetterHelp recovery, share gains, new products and margin expansion, none of which is contracted or has a multi-year record. The acquired-intangible amortization is treated as a wasting asset through the declining growth path rather than by lowering the earnings level. Bear case: $0.80 per share. BetterHelp keeps shrinking at its 2025 pace (revenue down 9%, paying users down 5%), Integrated Care revenue does not offset it, and the $1.0 billion of 1.25% convertible notes due in 2027 is refinanced at a much higher rate, cutting per-share earnings to about $0.15. Earnings then fall about 8% a year and fade to nothing. The Integrated Care segment is also concentrated: its top five clients were 31% of segment revenue. Bull case: $4.80 per share. The 2025 level of $0.41 holds for five years, since cost cuts are already in the numbers and Integrated Care is growing modestly, then declines 2% a year for five years and 5% a year after that. This assumes no growth, only that recent earnings hold. What would make this wrong. The value rests on stock compensation staying near $80 million and capitalized software near $120 million a year. Higher software spending to compete with better-funded rivals would eliminate most of the owner earnings, as it did in 2022-2023, when they were negative. Conversely, stabilization of BetterHelp's user base would put us in the bull case. Debt is considered only through the bear case: the 2027 notes are due in about eight months and were covered at year-end 2025 by roughly $781 million of cash plus about $294 million of annual operating cash flow. The margin-of-safety price of $1.80 builds in a large cushion because the earnings base is thin relative to its swings, one segment is shrinking and the earnings history is short.
Fiscal yearOwner's earningsMethodology
2025 $0.41 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$294.36M; net WC cash effect=+$14.70M inflow (removed); SBC=$80.41M; capex $8.89M + capitalized software $118.56M = $127.46M; revenue declined so growth capex=$0, maintenance capex=$127.46M; OE=$71.8M; diluted shares=176.22M; OE/sh=$0.41. Source: FY2025 10-K accession 0001477449-26-000012.
2024 $0.29 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$293.68M; net WC cash effect=$(25.42)M outflow (add back +$25.42M); SBC=$145.95M; capex $10.79M + capitalized software $113.26M = $124.05M; revenue declined so growth capex=$0, maintenance capex=$124.05M; OE=$49.1M; diluted shares=170.56M; OE/sh=$0.29. Source: FY2025 10-K accession 0001477449-26-000012 (FY2024 column).
2023 -$0.12 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$350.02M; net WC cash effect=+$21.87M inflow (removed); SBC=$201.55M; capex $11.46M + capitalized software $144.88M = $156.35M; growth capex=5.24% x $195.6M=$10.25M, maintenance capex=$146.1M; OE=$(19.5)M; diluted shares=164.58M; OE/sh=$(0.12). Source: FY2025 10-K accession 0001477449-26-000012 (FY2023 column).
2022 -$0.90 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$189.29M; net WC cash effect=$(36.86)M outflow (add back +$36.86M); SBC=$217.85M; capex $16.48M + capitalized software $156.28M = $172.76M; capex ratio (5-yr mean FY21-25)=5.24%, growth capex=5.24% x $374.1M revenue increase=$19.6M, maintenance capex=$153.2M; OE=$(144.9)M; diluted shares=161.46M; OE/sh=$(0.90). Source: FY2023 10-K accession 0001477449-24-000023 (FY2022 column).
2021 -$0.92 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$193.99M; net WC cash effect (AR, prepaids, inventory, other assets, AP, accrued, accrued comp, deferred revenue, other liabs; operating lease liabilities excluded as they pair with ROU amortization)=$(27.45)M outflow so ΔWC add-back +$27.45M; SBC=$302.59M; capex $8.53M + capitalized software $55.40M = $63.93M; revenue growth was Livongo-merger driven so growth capex=$0, maintenance capex=$63.93M; OE=$(145.08)M; diluted shares=156.94M; OE/sh=$(0.92). Capitalized software treated as capex (recurring cost). Source: FY2023 10-K accession 0001477449-24-000023 (FY2021 column).

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (about 82% of 2025 revenue) plus international markets (about 18%, growing), including Canada, the United Kingdom, Australia and continental Europe
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis

We don't have chart analysis for this company yet.

Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.